December 2014 | OncologyLive

A Time of Hope in Lung Cancer

December 20, 2014

Leading researchers described several areas of significant advances during the 9th Annual New York Lung Cancer Symposium, a daylong conference that Physicians' Education Resource hosted November 8.

A New World of Targeted Therapies for HER2-Positive Breast Cancer Takes Shape

December 17, 2014

When added to standard chemotherapy, trastuzumab not only dramatically improved disease-free survival rates for patients with metastatic disease, but also resulted in a clear survival advantage unprecedented for most treatments of metastatic breast cancer.

The New BRCA1/2 Landscape

December 13, 2014

As one of the most significant predictors of hereditary breast and ovarian cancer, the BRCA1/2 genes have become the poster child for genetic testing, thrust into the limelight by a high-profile court battle and a celebrity's disclosure.

The Emerging "N-of-1" Model:Clinical Relevance of Individualized Tumor Profiling Grows in Research Programs

November 28, 2014

Molecular studies are increasingly utilized to develop an individual therapeutic approach based on abnormalities present in the setting of uncommon/rare cancers or in specific clinical situations where it is virtually certain that formal regulatory-based trials will never be undertaken.